Predictions
Abiomed Inc.
Start price
Target price
Perf. (%)
€266.60
29.04.21
29.04.21
€245.00
29.04.22
29.04.22
-10.43%
07.06.21
07.06.21
Could be worthwhile Investment >10% per year
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€56.02
06.04.21
06.04.21
€60.00
06.04.22
06.04.22
3.82%
01.07.21
01.07.21
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€152.98
25.03.21
25.03.21
€140.00
25.09.21
25.09.21
25.83%
28.06.21
28.06.21
Could be worthwhile Investment >10% per year
Known brand
Medium risks for its business
overvalued
Johnson & Johnson
Start price
Target price
Perf. (%)
€136.62
24.03.21
24.03.21
€145.00
24.03.22
24.03.22
-1.26%
09.04.21
09.04.21
Known brand
Future proof or reliable business model
Medium risks for its business
Pfizer Inc.
Start price
Target price
Perf. (%)
€29.35
15.03.21
15.03.21
€50.00
15.03.22
15.03.22
43.43%
09.11.21
09.11.21
Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Agilent Technologies Inc.
Start price
Target price
Perf. (%)
€101.00
09.03.21
09.03.21
€120.00
09.03.22
09.03.22
19.46%
10.03.22
10.03.22
Could be worthwhile Investment >10% per year
Zoetis Inc. A
Start price
Target price
Perf. (%)
€130.34
27.02.21
27.02.21
-
27.02.22
27.02.22
37.81%
20.01.22
20.01.22
Innovative
Medium risks for its business
Top 10 in its market
Future proof or reliable business model
Incyte Corp.
Start price
Target price
Perf. (%)
€64.63
25.02.21
25.02.21
€70.00
3.84%
08.03.21
08.03.21
Could be worthwhile Investment >10% per year
Incyte Corp.
Start price
Target price
Perf. (%)
€67.64
24.02.21
24.02.21
-
24.02.22
24.02.22
-12.39%
25.11.21
25.11.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Dependend from some customers or products
Hologic Inc.
Start price
Target price
Perf. (%)
€62.50
24.02.21
24.02.21
-
24.02.22
24.02.22
1.60%
30.03.21
30.03.21
Probably not worthwhile Investment
Teleflex Inc.
Start price
Target price
Perf. (%)
€320.00
21.02.21
21.02.21
-
21.02.22
21.02.22
14.38%
23.04.21
23.04.21
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
Perrigo Co. plc
Start price
Target price
Perf. (%)
€37.00
15.02.21
15.02.21
-
15.02.22
15.02.22
5.95%
11.07.21
11.07.21
Could be worthwhile Investment >10% per year
Undervalued
Higher risks for its business
Viatris Inc.
Start price
Target price
Perf. (%)
€15.40
15.02.21
15.02.21
€19.00
15.02.22
15.02.22
-14.92%
15.02.22
15.02.22
Undervalued
High dividend yield expected
Idexx Laboratories Inc.
Start price
Target price
Perf. (%)
€416.00
06.02.21
06.02.21
-
06.02.22
06.02.22
7.91%
25.05.21
25.05.21
EBIT growth >5% per year expected
Very low/no dividend yield expected
Johnson & Johnson
Start price
Target price
Perf. (%)
€138.90
05.02.21
05.02.21
-
31.12.21
31.12.21
0.09%
29.03.21
29.03.21
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
Becton, Dickinson & Co.
Start price
Target price
Perf. (%)
€222.00
01.02.21
01.02.21
€260.00
30.03.22
30.03.22
-6.17%
09.10.21
09.10.21
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€173.98
25.01.21
25.01.21
€250.00
25.01.22
25.01.22
23.00%
17.01.22
17.01.22
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€463.95
25.01.21
25.01.21
€500.00
25.01.22
25.01.22
15.42%
26.01.22
26.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Intuitive Surgical Inc
Start price
Target price
Perf. (%)
€219.23
21.01.21
21.01.21
€215.00
2.46%
15.02.21
15.02.21
Known brand
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Johnson & Johnson
Start price
Target price
Perf. (%)
€134.68
20.01.21
20.01.21
€144.00
0.89%
02.02.21
02.02.21
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€55.31
19.01.21
19.01.21
€67.00
19.01.22
19.01.22
14.53%
20.01.22
20.01.22
Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Medtronic plc
Start price
Target price
Perf. (%)
€97.71
10.01.21
10.01.21
-
10.01.22
10.01.22
-2.05%
11.01.22
11.01.22
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Known brand
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€51.89
09.01.21
09.01.21
€68.00
09.01.22
09.01.22
8.15%
30.10.21
30.10.21
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€48.93
05.01.21
05.01.21
-
05.01.22
05.01.22
10.78%
03.06.21
03.06.21
Could be worthwhile Investment >10% per year
Capable Management
Innovative
Market Leader or Top 3